Skip to main content

Table 1 Definition of variables

From: Organizational changes in diabetic foot care practices for patients at low and moderate risk after implementing a comprehensive foot care program in Alberta, Canada

Question numberVariableDefinition / options
General Questions
 1Health zoneGeographic region within Alberta (North, Edmonton, Central, Calgary, South) or other (e.g. Federal)
 2Area of practicePrimary care network, home care, long-term care community (e.g. chronic disease management nurses working in the community), outpatient departments, wound clinics, other
 3Identification of siteFree text (e.g. specific clinic or hospital site)
 4Footcare related continuing educationFor all staff in setting within past 2 years; DON SCN sponsored symposia in 2017 or 2018; DON SCN-led workshops in various settings as part of intervention roll-out; Diabetes Canada sponsored events; other
 5Basic foot screening offeredYes/No
If Yes to #5, then…
 6Screening tool usedAHS screening tool (2019 only), 60-s foot screening tool, other (free text)
 7Screening settingFree text
 8Risk category seenLow, moderate, high risk, urgent care required, other
Questions regarding moderate-risk patients
 9Formalized clinic for assessmentYes (HRFT or other), no
If Yes to #9, then…
 10Management of skin/nail abnormalitiesPerform skin/nail care in practice area; provide list of foot/nail care providers in the community; refer to podiatrist or footcare nurse (i.e. private services), refer to HRFT, other (free text), none of the above
 11Management of structural deformitiesProvide education regarding self-management; refer to podiatrist or orthopedics; other (free text), none of the above
 12Management of footwearProvide education/information regarding footwear selection; refer to HRFT; provide referral for footwear/orthotics through AADL; refer for footwear/orthotics without AADL authorization; other (free text), none of the above
 13Management of vascular problemsPerform vascular assessment; refer to HRFT; refer to general practitioner; refer to vascular lab, other (free text), none of the above
 14Vascular assessment tests performedABPI; PPG; Pedal pulses; refer to HRFT; other (free text)
 15Management of loss of protective sensationTreat neuropathic pain (free text); refer to physician/nurse practitioner for treatment of neuropathic pain; refer to HRFT
 16Reassessment frequency1–3 months; 4–6 months; 7–12 months; no formalized schedule; other (free text)
 17Any other comments about moderate risk patientsFree text
 18Assess high risk/urgent patientsYes/No. If yes to these, a series of questions was asked. These responses are not reported in this article.